Computational models on quantitative prediction of bioactivity of HIV-1 integrase 3’ processing inhibitors

References

• United Nations. Available at http://www.unaids.org/en/dataanalysis/.
   Google Scholar
• M.L. Barreca, S. Ferro, A. Rao, L.D. Luca, M. Zappala, A.M. Monforte, Z. Debyser, M. Witvrouw, and A. Chimirri, Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors, J. Med. Chem. 48 (2005), pp. 7084–7088.10.1021/jm050549e
   PubMed Web of Science ®Google Scholar
• G. Le, N. Vandegraaff, D.I. Rhodes, E.D. Jones, J.A.V. Coates, N. Thienthong, L.J. Winfield, L. Lu, X. Li, C. Yu, X. Feng, and J.J. Deadman, Design of a series of bicyclic HIV-1 integrase inhibitors. Part 2: Azoles: Effective metal chelators, Bioorg. Med. Chem. Lett. 20 (2010), pp. 5909–5912.10.1016/j.bmcl.2010.07.081
   PubMed Web of Science ®Google Scholar
• D.D. Richman, HIV chemotherapy, Nature 410 (2001), pp. 995–1001.10.1038/35073673
   PubMed Web of Science ®Google Scholar
• C. Charpentier, M. Karmochkine, D. Laureillard, P. Tisserand, L. Belec, L. Weiss, A. Si-Mohamed, and C. Piketty, Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy, HIV Med. 9 (2008), pp. 765–770.10.1111/hiv.2008.9.issue-9
   PubMed Web of Science ®Google Scholar
• L. Yang, X. Xu, Y. Huang, B. Zhang, C. Zeng, H. He, C. Wang, and L. Hu, Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor, Bioorg. Med. Chem. Lett. 20 (2010), pp. 5469–5471.10.1016/j.bmcl.2010.07.087
   PubMed Web of Science ®Google Scholar
• D. Esposito and R. Craigie, HIV integrase structure and function, Adv. Virus. Res. 52 (1999), pp. 319–333.10.1016/S0065-3527(08)60304-8
   PubMed Web of Science ®Google Scholar
• C. Benard, F. Zhouhiri, M. Normand-Bayle, M. Danet, D. Desmaele, H. Leh, J.F. Mouscadet, G. Mbemba, C.M. Thomas, S. Bonnenfant, M.L. Bret, and J. d’Angelo, Linker-modified quinoline derivatives targeting HIV-1 integrase: Synthesis and biological activity, Bioorg. Med. Chem. Lett. 14 (2004), pp. 2473–2476.10.1016/j.bmcl.2004.03.005
   PubMed Web of Science ®Google Scholar
• G. Chi, N. Neamati, and V. Nair, Inhibition of the strand transfer step of HIV-1 integrase by non-natural dinucleotides, Bioorg. Med. Chem. Lett. 14 (2004), pp. 4815–4817.10.1016/j.bmcl.2004.07.050
   PubMed Web of Science ®Google Scholar
• E.E. Boros, B.A. Johns, E.P. Garvey, C.S. Koble, and W.H. Miller, Synthesis and HIV-integrase strand transfer inhibition activity of 7-hydroxy [1, 3] thiazolo [5, 4-b] pyridin-5 (4H)-ones, Bioorg. Med. Chem. Lett. 16 (2006), pp. 5668–5672.10.1016/j.bmcl.2006.08.007
   PubMed Web of Science ®Google Scholar
• V. Summa, A. Petrocchi, F. Ronelli, B. Crescenzi, M. Donghi, M. Ferrara, F. Fiore, C. Gardelli, O.G. Paz, D.J. Hazuda, P. Jones, O. Kinzel, R. Laufer, E. Monteagudo, E. Muraglia, E. Nizi, F. Orvieto, P. Pace, G. Pescatore, R. Scarpelli, K. Stillmock, M.V. Witmer, and M. Rowley, Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection, J. Med. Chem. 51 (2008), pp. 5843–5855.10.1021/jm800245z
   PubMed Web of Science ®Google Scholar
• A. Yan, S. Xuan, and X. Hu, Classification of active and weakly active ST inhibitors of HIV-1 integrase using a support vector machine, Comb. Chem. High. Throughput Screen 15 (2012), pp. 792–805.
   PubMed Web of Science ®Google Scholar
• S. Xuan, Y. Wu, X. Chen, J. Liu, and A. Yan, Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine, Bioorg. Med. Chem. Lett. 23 (2013), pp. 1648–1655.10.1016/j.bmcl.2013.01.081
   PubMed Web of Science ®Google Scholar
• H. Zhao, N. Neamati, H. Hong, A. Mazumder, S. Wang, S. Sunder, G.W.A. Milne, Y. Pommier, and T.R. Burke, Coumarin-based inhibitors of HIV integrase, J. Med. Chem. 40 (1997), pp. 242–249.10.1021/jm960450v
   PubMed Web of Science ®Google Scholar
• Z. Lin, N. Neamati, H. Zhao, Y. Kiryu, J.A. Turpin, C. Aberham, K. Strebel, K. Kohn, M. Witvrouw, C. Pannecouque, Z. Debyser, E.D. Clercq, W.G. Rice, and T.R. Burke, Chicoric acid analogues as HIV-1 integrase inhibitors, J. Med. Chem. 42 (1999), pp. 1401–1414.10.1021/jm980531m
   PubMed Web of Science ®Google Scholar
• D.C. Meadows, T.B. Mathews, T.W. North, M.J. Hadd, C.L. Kuo, N. Neamati, and J. Gervay-Hague, Synthesis and biological evaluation of geminal disulfones as hiv-1 integrase inhibitor, J. Med. Chem. 45 (2005), pp. 4526–4534.10.1021/jm049171v
   Web of Science ®Google Scholar
• N. Neamati, H. Hong, A. Mazumder, S. Wang, S. Sunder, M.C. Nicklaus, G.W.A. Milne, B. Proksa, and Y. Pommier, Depsides and depsidones as inhibitors of HIV-1 integrase: Discovery of novel inhibitors through 3D database searching, J. Med. Chem. 40 (1997), pp. 942–951.10.1021/jm960759e
   PubMed Web of Science ®Google Scholar
• H. Zhao, N. Neamati, S. Sunder, H. Hong, S. Wang, G.W.A. Milne, Y. Pommier, and T.R. Burke, Hydrazide-containing inhibitors of HIV-1 integrase, J. Med. Chem. 40 (1997), pp. 937–941.10.1021/jm960755+
   PubMed Web of Science ®Google Scholar
• M. Sechi, M. Derudas, R. Dallocchio, A. Dessi, A. Bacchi, L. Sannia, F. Carta, M. Palomba, O. Ragab, and C. Chan, Design and synthesis of novel indole β-diketo acid derivatives as HIV-1 integrase inhibitors, J. Med. Chem. 47 (2004), pp. 5298–5310.10.1021/jm049944f
   PubMed Web of Science ®Google Scholar
• S.N. Kim, J.Y. Lee, H.J. Kim, C.G. Shin, H. Park, and Y.S. Lee, Synthesis and HIV-1 integrase inhibitory activities of caffeoylglucosides, Bioorg. Med. Chem. Lett. 10 (2000), pp. 1879–1882.10.1016/S0960-894X(00)00355-3
   PubMed Web of Science ®Google Scholar
• N. Neamati, J.A. Turpin, H.E. Winslow, J.L. Christensen, K. Williamson, A. Orr, W.G. Rice, Y. Pommier, A. Garofalo, A. Brizzi, G. Gampiani, I. Fiorini, and V. Nacci, Thiazolothiazepine inhibitors of HIV-1 integrase, J. Med. Chem. 42 (1999), pp. 3334–3341.10.1021/jm990047z
   PubMed Web of Science ®Google Scholar
• Y. Goldgur, R. Craigie, G.H. Cohen, T. Fujiwara, T. Yoshinaga, T. Fujishita, H. Sugimoto, T. Endo, H. Murai, and D.R. Davies, Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design, Proc. Natl. Acad. Sci. U.S.A. 96 (1996), pp. 13040–13043.
   Web of Science ®Google Scholar
• J. Wielens, S.J. Headey, J.J. Deadman, D.I. Rhodes, G.T. LeM.W. Parker, D.K. Chalmers, and M.J. Scanlon, and M.J. Scanlon, Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1, Chem. Med. Chem. 6 (2011), pp. 258–261.10.1002/cmdc.201000483
   Web of Science ®Google Scholar
• D.I. Rhodes, T.S. Peat, N. Vandegraaff, D. Jeevarajah, G. Le, E.D. Jones, J.A. Smith, J.A. Coates, L.J. Winfield, N. Thienthong, J. Newman, D. Lucent, J.H. Ryan, G.P. Savage, C.L. Francis, and J.J. Deadman, Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design, Antivir. Chem. Chemother 21 (2011), pp. 155–168.10.3851/IMP1716
   PubMedGoogle Scholar
• T.S. Peat, D.I. Rhodes, N. Vandegraaff, G. Le, J.A. Smith, L.J. Clark, E.D. Jones, J.A. Coates, N. Thienthong, and J. Newman, Small molecule inhibitors of the LEDGF site of human immunodeficiency virus integrase identified by fragment screening and structure based design, PloS One 7 (2012), p. e40147.10.1371/journal.pone.0040147
   PubMed Web of Science ®Google Scholar
• M. Tsiang, G.S. Jones, A. Niedziela-Majka, E. Kan, E.B. Lansdon, W. Huang, M. Hung, D. Samuel, N. Novikov, and Y. Xu, New class of HIV-1 integrase (IN) inhibitors with a dual mode of action, J. Biol. Chem. 287 (2012), pp. 21189–21203.10.1074/jbc.M112.347534
   PubMed Web of Science ®Google Scholar
• P.V. Khadikar, V. Sharma, S. Karmarkar, and T. Supuran, QSAR studies on benzene sulfonmide carbonic anhydrase inhibitors: Need of hydrophpbic parameter for topological modeling of binding constants of sulfonamides to human CA-II, Med. Chem. Lett. 15 (2005), pp. 923–930.10.1016/j.bmcl.2004.12.056
   PubMed Web of Science ®Google Scholar
• MOE (The Molecular Operating Environment), Version 2009.10; software available from Chemical Computing Group Inc., 1010 Sherbrook Street West, Suite 910, Montral, Canada H3A 2R7
   Google Scholar
• T. Kohonen, Self-organized formation of topologically correct feature maps, Biol. Cybern. 43 (1982), pp. 59–69.10.1007/BF00337288
   Web of Science ®Google Scholar
• C.C. Chang and C.J. Lin, LIBSVM: A library for support vector machine, 2013. available at http://www.csie.ntu.edu.tw/~cjlin/libsvm, 2013.
   Google Scholar
• K. Raghavan, J.K. Buolamwini, M.R. Fesen, Y. Pommier, K.W. Kohn, and J.N. Weinstein, Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: A comparative molecular field analysis (COMFA) study, J. Med. Chem. 38 (1995), pp. 890–897.10.1021/jm00006a006
   PubMed Web of Science ®Google Scholar
• M.C. Nicklaus, N. Neamati, H. Hong, A. Mazumder, S. Sunder, J. Chen, G.W.A. Milne, and Y. Pommier, HIV-1 integrase pharmacophore: Discovery of inhibitors through three-dimensional database searching, J. Med. Chem. 40 (1997), pp. 920–929.10.1021/jm960596u
   PubMed Web of Science ®Google Scholar
• H. Zhao, N. Neamati, A. Mazumder, S. Sunder, Y. Pommier, and T.R. Burke, Arylamide inhibitors of HIV-1 integrase, J. Med. Chem. 40 (1997), pp. 1186–1194.10.1021/jm960449w
   PubMed Web of Science ®Google Scholar
• X. Zhang, G.C.G. Pais, E.S. Svarovskaia, C. Marchand, A.A. Johnson, R.G. Karki, M.C. Nicklaus, V.K. Pathak, Y. Pommier, and T.R. Burke, Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors, Bioorg. Med. Chem. Lett. 13 (2003), pp. 1215–1219.10.1016/S0960-894X(03)00059-3
   PubMed Web of Science ®Google Scholar
• M. Artico, R. Di Santo, R. Costi, E. Novellino, G. Greco, S. Massa, E. Tramontano, M.E. Marongiu, A. De Montis, and P. La Colla, Geometrically and Conformationally Restrained Cinnamoyl Compounds as Inhibitors of HIV-1 Integrase:  Synthesis, Biological Evaluation, and Molecular Modeling, J. Med. Chem. 41 (1998), pp. 3948–3960.10.1021/jm9707232
   PubMed Web of Science ®Google Scholar
• R. Di Santo, R. Costi, A. Roux, M. Artico, A. Lacecchia, L. Marinelli, E. Novellino, L. Palmisano, M. Andreotti, R. Amici, C.M. Galluzzo, L. Nencioni, A.T. Palamara, Y. Pommier, and C. Marchand, Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: Design, synthesis, biological activities, and mechanism of action, J. Med. Chem. 49 (2006), pp. 1939–1945.10.1021/jm0511583
   PubMed Web of Science ®Google Scholar
• Y.Q. Long, X.H. Jiang, R. Dayam, T. Sanchez, R. Shoemaker, S. Sei, and N. Neamati, Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: Implication for binding to two metal ions on the active site of integrase, J. Med. Chem. 47 (2004), pp. 2561–2573.10.1021/jm030559k
   PubMed Web of Science ®Google Scholar
• V. Nair, G. Chi, R. Ptak, and N. Neamati, HIV integrase inhibitors with nucleobase scaffolds: Discovery of a highly potent anti-HIV agent, J. Med. Chem. 49 (2006), pp. 445–447.10.1021/jm0508890
   PubMed Web of Science ®Google Scholar
• K. Mekouar, J. Mouscadet, D. Desmaele, F. Subra, H. Leh, D. Savoure, C. Auclair, and J. d’Angelo, Styrylquinoine derivatives: A new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells, J. Med. Chem. 41 (1998), pp. 2846–2857.10.1021/jm980043e
   PubMed Web of Science ®Google Scholar
• F. Zouhiri, J. Mouscadet, K. Mekouar, D. Desmaele, D. Sacoure, H. Leh, F. Subra, M.L. Bret, C. Auclair, and J. d’Angelo, Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture, J. Med. Chem. 43 (2000), pp. 1533–1540.10.1021/jm990467o
   PubMed Web of Science ®Google Scholar
• R. Costi, R. Di Santo, M. Artico, A. Roux, R. Ragno, S. Massa, E. Tramontano, M.L. Colla, R. Loddo, M.E. Marongiu, A. Pani, and P.L. Colla, 6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays, Bioorg. Med. Chem. Lett 14 (2004), pp. 1745–1749.10.1016/j.bmcl.2004.01.037
   PubMed Web of Science ®Google Scholar
• G.C. Pais, X. Zhang, C. Marchand, N. Neamati, K. Cowansage, E.S. Svarovskaia, V.K. Pathak, Y. Tang, M. Nicklaus, Y. Pommier, and T.R. Burke, Structure activity of 3-Aryl-1, 3-diketo-containing compounds as HIV-1integrase inhibitors, J. Med. Chem. 45 (2002), pp. 3184–3194.10.1021/jm020037p
   PubMed Web of Science ®Google Scholar
• N. Neamati, H. Hong, J.M. Owen, S. Sunder, H.E. Winslow, J.L. Christensen, H. Zhao, T.R. Burke, G.W.A. Milne, and Y. Pommier, Salicylhydrazine-containing inhibitors of HIV-1 integrase: Implication for a selective chelation in the integrase active site, J. Med. Chem. 41 (1998), pp. 3202–3209.10.1021/jm9801760
   PubMed Web of Science ®Google Scholar
• N. Neamati, Z. Lin, R.G. Karki, A. Orr, K. Cowansage, D. Strumberg, G.C.G. Pais, J.H. Voigt, M.C. Nicklaus, H.E. Winslow, H. Zhao, J.A. Turpin, J. Yi, A.M. Skalka, T.R. Bruke, and Y. Pommier, Metal-dependent inhibition of HIV-1 integrase, J. Med. Chem. 45 (2002), pp. 5661–5670.10.1021/jm0201417
   PubMed Web of Science ®Google Scholar
• H. Hong, N. Neamati, S. Wang, M.C. Nicklaus, A. Mazumder, H. Zhao, T.R. Burke, Y. Pommier, and G.W.A. Milne, Discovery of HIV-1 integrase inhibitors by pharmacophore searching, J. Med. Chem. 40 (1997), pp. 930–936.10.1021/jm960754h
   PubMed Web of Science ®Google Scholar
• A. Mazumder, S. Wang, N. Neamati, M. Nicklaus, S. Sunder, J. Chen, G.W.A. Milne, W.G. Rice, T.R. Burke, and Y. Pommier, Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease, J. Med. Chem. 39 (1996), pp. 2472–2481.10.1021/jm960074e
   PubMed Web of Science ®Google Scholar
• R. Dupont, L. Jeanson, J.F. Mouscadet, and P. Cotelle, Synthesis and HIV-1 integrase inhibitory activities of catechol and bis-catechol derivatives, Bioorg. Med. Chem. Lett. 11 (2011), pp. 3175–3178.
   Web of Science ®Google Scholar
• V. Nair, V. Uchil, and N. Neamati, β-diketo acids with purine nucleobase scaffolds: Novel, selective inhibitors of the strand transfer step of HIV integrase, Bioorg. Med. Chem. Lett. 16 (2006), pp. 1920–1923.10.1016/j.bmcl.2005.12.093
   PubMed Web of Science ®Google Scholar
• A. Mazumder, N. Neamati, S. Sunder, J. Schulz, H. Pertz, E. Eich, and Y. Pommier, Curcumin analogs with altered potencies against HIV-1 integrase probes for biochemical mechanisms of drug action, J. Med. Chem. 40 (1997), pp. 3057–3063.10.1021/jm970190x
   PubMed Web of Science ®Google Scholar
• J.Y. Lee, K.J. Yoon, and Y.S. Lee, Catechol-substituted L-chicoric acid analogues as HIV integrase inhibitors, Bioorg. Med. Chem. Lett. 13 (2003), pp. 4331–4334.10.1016/j.bmcl.2003.09.046
   PubMed Web of Science ®Google Scholar
• R. Dayam, T. Sanchez, and N. Neamati, Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase, J. Med. Chem. 48 (2005), pp. 8009–8015.10.1021/jm050837a
   PubMed Web of Science ®Google Scholar
• J. Deng, K.W. Lee, T. Sanchez, M. Cui, N. Neamati, and J.M. Briggs, Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors, J. Med. Chem. 48 (2005), pp. 1496–1505.10.1021/jm049410e
   PubMed Web of Science ®Google Scholar
• J. Deng, T. Sanchez, N. Neamati, and J.M. Briggs, Dynamic pharmacophore model optimization: Identification of novel HIV-1 integrase inhibitors, J. Med. Chem. 49 (2006), pp. 1684–1692.10.1021/jm0510629
   PubMed Web of Science ®Google Scholar
• D.C. Meadows, T. Sanchez, N. Neamati, T.W. North, and J. Gervay-Hague, Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1, Bioorg. Med. Chem. 15 (2007), pp. 1127–1137.10.1016/j.bmc.2006.10.017
   PubMed Web of Science ®Google Scholar
• J.K. Buolamwini and H. Assefa, CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: Exploration of a binding mode at the active site, J. Med. Chem. 45 (2002), pp. 841–852.10.1021/jm010399h
   PubMed Web of Science ®Google Scholar
• C.L. Kuo, H. Assefa, S. Kamath, Z. Brzozowski, J. Slawinski, F. Saqczewski, J.K. Buolamwini, and N. Neamati, Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors, J. Med. Chem. 47 (2004), pp. 385–399.10.1021/jm030378i
   PubMed Web of Science ®Google Scholar
• M. Sechi, G. Rizzi, A. Bacchi, M. Carcelli, D. Rogolino, N. Pala, T.W. Sanchez, L. Taheri, R. Dayam, and N. Neamati, Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors, Bioorg. Med. Chem. 17 (2009), pp. 2925–2935.10.1016/j.bmc.2008.10.088
   PubMed Web of Science ®Google Scholar
• V. Hadi, Y.H. Koh, T.W. Sanchez, D. Barrios, N. Neamati, and K.W. Jung, Development of the next generation of HIV-1 integrase inhibitors: Pyrazolone as a novel inhibitor scaffold, Bioorg. Med. Chem. Lett. 20 (2010), pp. 6854–6857.10.1016/j.bmcl.2010.08.057
   PubMed Web of Science ®Google Scholar
• K. Ramkumar, V.N. Yarovenko, A.S. Nikitina, I.V. Zavarzin, M.M. Krayushkin, L.V. Kovalenko, A. Esqueda, S. Odde, and N. Neamati, Design, synthesis and structure-activity studies of rhodanine derivatives as HIV-1 integrase inhibitors, Molecules 15 (2010), pp. 3958–3992.10.3390/molecules15063958
   PubMed Web of Science ®Google Scholar
• P. Vandurm, A. Guiguen, C. Cauvin, B. Georges, V.K. Le, C. Michaux, C. Cardona, G. Mbemba, L. Hevesi, L.C. Van, and J. Wouters, Synthesis, biological evaluation and molecular modeling of quinolonyl diketo acid derivatives: New structural insight into the HIV-1 integrase inhibition, Eur. J. Med. Chem. 46 (2011), pp. 1749–1756.10.1016/j.ejmech.2011.02.028
   PubMed Web of Science ®Google Scholar
• H. Sharma, S. Patil, T.W. Sanchez, N. Neamati, R.F. Schinazi, and J.K. Buolamwini, Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors, Bioorg. Med. Chem. 19 (2011), pp. 2030–2045.10.1016/j.bmc.2011.01.047
   PubMed Web of Science ®Google Scholar
• F. Bailly, C. Queffelec, G. Mbemba, J.F. Mouscadet, N. Pommery, J. Pommery, J.P. Henichart, and P. Cotelle, Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones, Eur. J. Med. Chem. 43 (2008), pp. 1222–1229.10.1016/j.ejmech.2007.08.005
   PubMed Web of Science ®Google Scholar
• Z. Brzozowski, J. Slawinski, F. Saczewski, T. Sanchez, and N. Neamati, Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives, Eur. J. Med. Chem. 43 (2008), pp. 1188–1198.10.1016/j.ejmech.2007.08.013
   PubMed Web of Science ®Google Scholar
• Z. Brzozowski, F. Saczewski, T. Sanchez, C.L. Kuo, M. Gdaniec, and N. Neamati, Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines, Bioorg. Med. Chem. 12 (2004), pp. 3663–3672.10.1016/j.bmc.2004.04.024
   PubMed Web of Science ®Google Scholar
• R. Dayam, L.Q. Al-Mawsawi, and N. Neamati, Substituted 2-pyrrolinone inhibitors of HIV-1 integrase, Bioorg. Med. Chem. Lett. 17 (2007), pp. 6155–6159.10.1016/j.bmcl.2007.09.061
   PubMed Web of Science ®Google Scholar
• L.Q. Al-Mawsawi, M. Sechi, and N. Neamati, Single amino acid substitution in HIV-1 integrase catalytic core causes a dramatic shift in inhibitor selectivity, FEBS Lett. 581 (2007), pp. 1151–1156.10.1016/j.febslet.2007.02.023
   PubMed Web of Science ®Google Scholar
• S. Patil, S. Kamath, T. Sanchez, N. Neamati, R.F. Schinazi, and J.K. Buolamwini, Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors, Bioorg. Med. Chem. Lett. 15 (2007), pp. 1212–1228.10.1016/j.bmc.2006.11.026
   Web of Science ®Google Scholar
• L.F. Zeng, X.H. Jiang, T. Sanchez, H.S. Zhang, R. Dayam, N. Neamati, and Y.Q. Long, Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: Effects of the phenyl substituent and the linker orientation, Bioorg. Med. Chem. 16 (2008), pp. 7777–7787.10.1016/j.bmc.2008.07.008
   PubMed Web of Science ®Google Scholar
• R. Dayam, T. Sanchez, and N. Neamati, Discovery and structure–activity relationship studies of a unique class of HIV1 integrase inhibitors, Chem. Med. Chem. 1 (2006), pp. 238–244.10.1002/(ISSN)1860-7187
   Google Scholar
• C. Maurin, F. Bailly, G. Mbemba, J.F. Mouscadet, and P. Cotelle, Design, synthesis, and anti-integrase activity of catechol-DKA hybrids, Bioorg. Med. Chem. 14 (2006), pp. 2978–2984.10.1016/j.bmc.2005.12.039
   PubMed Web of Science ®Google Scholar
• F. Aiello, A. Brizzi, A. Garofalo, F. Grande, G. Ragno, R. Dayam, and N. Neamati, Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors, Bioorg. Med. Chem. 12 (2004), pp. 4459–4466.10.1016/j.bmc.2004.05.037
   PubMed Web of Science ®Google Scholar
• R. Costi, R. Di Santo, M. Artico, S. Massa, P. Raqno, R. Loddo, C.M. La, E. Tramontano, C.P. La, and A. Pani, 2,6-bis(3,4,5-thihydroxybenzylydene) derivatives of cyclohexanone: Novel potent HIV-1 integrase inhibitors that prevent HIV-1 multiplication in cell-based assays, Bioorg. Med. Chem. Lett. 12 (2004), pp. 199–215.10.1016/j.bmc.2003.10.005
   Web of Science ®Google Scholar
• CORINA, Molecular Networks GmbH, Erlangen, Germany, available from http://www.molecular-networks.com (accessed October 2013).
   Google Scholar
• SONNIA, available from Molecular Networks GmbH, Erlangen, Germany, available from http://www.molecular-networks.com (accessed October 2013).
   Google Scholar
• MACCS structural Keys, Symyx Software, San Ramon, CA, 2005.
   Google Scholar
• L.H. Hall and L.B. Kier, The molecular connectivity chi indices and kappa shape indices in structure-property modeling, Rev. Comput. Chem. 2 (1991), pp. 367–422.
   Google Scholar
• M. Petitjean, Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds, J. Chem. Inf. Comput. Sci. 32 (1992), pp. 331–337.10.1021/ci00008a012
   Google Scholar
• A.X. Yan, Z. Wang, and Z.Y. Cai, Prediction of human intestinal absorption by GA feature selection and support vector machine regression, Int. J. Mol. Sci. 9 (2008), pp. 1961–1976.10.3390/ijms9101961
   PubMed Web of Science ®Google Scholar
• G. Melagraki, A. Afantitis, H. Aarimvels, P.A. Koutentis, J. Markopoulos, and O. Igglessi-Markopoulou, Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure, Bioorg. Med. Chem. 15 (2007), pp. 7237–7247.10.1016/j.bmc.2007.08.036
   PubMed Web of Science ®Google Scholar
• D.E. Hinkle, W. Wiersma, and S.G. Jurs, Applied Statistics for the Behavioral Sciences, 5th ed., Houghton Mifflin, Boston, MA, 2003.
   Google Scholar
• J. Gasteiger and M. Marsili, Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges, Tetrahedron 36 (1980), pp. 3219–3228.10.1016/0040-4020(80)80168-2
   Web of Science ®Google Scholar
• J. Hinze and H. Jaffe, Electronegativity. I. Orbital electronegativity of neutral atoms, J. Am. Chem. Soc. 84 (1962), pp. 540–546.10.1021/ja00863a008
   Web of Science ®Google Scholar